HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.

Abstract
The membrane-bound chemokine fractalkine (FKN, CX3CL1) on endothelial cells plays a role in leukocyte trafficking. The chemokine domain (FKN-CD) is sufficient for inducing FKN signaling (e.g., integrin activation), and FKN-CD binds to its receptor CX3CR1 on leukocytes. Whereas previous studies suggest that FKN-CD does not directly bind to integrins, our docking simulation studies predicted that FKN-CD directly interacts with integrin α(v)β(3). Consistent with this prediction, we demonstrated that FKN-CD directly bound to α(v)β(3) and α(4)β(1) at a very high affinity (K(D) of 3.0 × 10(-10) M to α(v)β(3) in 1 mM Mn(2+)). Also, membrane-bound FKN bound to integrins α(v)β(3) and α(4)β(1), suggesting that the FKN-CD/integrin interaction is biologically relevant. The binding site for FKN-CD in α(v)β(3) was similar to those for other known α(v)β(3) ligands. Wild-type FKN-CD induced coprecipitation of integrins and CX3CR1 in U937 cells, suggesting that FKN-CD induces ternary complex formation (CX3CR1, FKN-CD, and integrin). Based on the docking model, we generated an integrin-binding defective FKN-CD mutant (the K36E/R37E mutant). K36E/R37E was defective in ternary complex formation and integrin activation, whereas K36E/R37E still bound to CX3CR1. These results suggest that FKN-CD binding to CX3CR1 is not sufficient for FKN signaling, and that FKN-CD binding to integrins as coreceptors and the resulting ternary complex formation are required for FKN signaling. Notably, excess K36E/R37E suppressed integrin activation induced by wild-type FKN-CD and effectively suppressed leukocyte infiltration in thioglycollate-induced peritonitis. These findings suggest that K36E/R37E acts as a dominant-negative CX3CR1 antagonist and that FKN-CD/integrin interaction is a novel therapeutic target in inflammatory diseases.
AuthorsMasaaki Fujita, Yoko K Takada, Yoshikazu Takada
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 189 Issue 12 Pg. 5809-19 (Dec 15 2012) ISSN: 1550-6606 [Electronic] United States
PMID23125415 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • CX3C Chemokine Receptor 1
  • Chemokine CX3CL1
  • Chemokines
  • Integrin alpha4beta1
  • Integrin alphaVbeta3
  • Receptors, Cytokine
  • Receptors, HIV
Topics
  • Animals
  • CHO Cells
  • CX3C Chemokine Receptor 1
  • Chemokine CX3CL1 (genetics, metabolism)
  • Chemokines (metabolism)
  • Computer Simulation
  • Cricetinae
  • Cricetulus
  • Humans
  • Integrin alpha4beta1 (metabolism)
  • Integrin alphaVbeta3 (metabolism)
  • K562 Cells
  • Mutation (genetics)
  • Protein Binding (genetics, immunology)
  • Protein Structure, Tertiary (genetics)
  • Receptors, Cytokine (antagonists & inhibitors, metabolism)
  • Receptors, HIV (antagonists & inhibitors, metabolism)
  • Signal Transduction (genetics, immunology)
  • U937 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: